Table 1 Patient demographics and clinical characteristics
No treated ROP (n = 189) | Treated ROP (n = 98) | p-value | *Adjusted p-value | |
|---|---|---|---|---|
GA (weeks) | 27.4 (± 1.1) | 25.5 (± 1.4) | < 0.001 | - |
Birthweight (g) | 1014 (± 228.7) | 747.6 (± 150.9) | < 0.001 | - |
SGA | 10 (5.3%) | 12 (12.2%) | 0.036 | 0.150 |
Male | 111 (58.7%) | 47 (48.0%) | 0.082 | 0.260 |
RDS | 141 (74.6%) | 95 (96.9%) | < 0.001 | 0.013 |
BPD | 158 (83.6%) | 95 (96.9%) | 0.001 | 0.400 |
Treated PDA | 102 (54.0%) | 77 (78.6%) | < 0.001 | 0.026 |
Sepsis | 22 (11.6%) | 36 (36.7%) | < 0.001 | 0.055 |
IVH ≥ Gr 3 | 58 (30.7%) | 47 (48.0%) | 0.004 | 0.332 |
PVL | 11 (5.8%) | 5 (5.1%) | 0.801 | 0.721 |
NEC | 11 (5.8%) | 10 (10.2%) | 0.176 | 0.801 |
Invasive ventilation (days) | 13.1 (± 18.8) | 46.3 (± 45.1) | < 0.001 | < 0.001 |
Hospital days | 82.1 (± 23.1) | 124.4 (± 54.5) | < 0.001 | < 0.001 |